Evaluation of Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron / Rebetol in Conjunction With a Patient Assistance Program - Non Interventional Observational Study.
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2014
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms COMPLETED
- Sponsors Merck Sharp & Dohme
- 21 Aug 2009 Primary outcome amended as reported by ClinicalTrials.gov.
- 23 Aug 2008 New trial record.